P-245Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy for patients with locally advanced pancreatic cancer. (2nd July 2019) - Paluri, R; Manne, U; Williams, G; Rose, B; Heslin, M; Reddy, S; Kyanam Kabir Baig, K; Vickers, S; Ali, A; Gbolahan, O; Smith, C; Jacob, R